NRD
AMN icon

Nebula Research & Development’s AMN Healthcare AMN Stock Holding History

Nebula Research & Development’s Portfolio AMN Stock Details AMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,187
Closed -$469K – 950
2025
Q1 		$469K Buy
19,187
+7,459
+64% +$192K 0.04% 626
2024
Q4 		$281K Buy
+11,728
New +$373K 0.03% 728
2024
Q3 		– Sell
-6,516
Closed -$334K – 921
2024
Q2 		$334K Buy
+6,516
New +$369K 0.05% 572

Other funds holding AMN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nebula Research & Development's AMN Position: Q2 2025 in Review

Nebula Research & Development sold out of AMN Healthcare (AMN) in Q2 2025, closing a stake of 19,187 shares — an estimated $469K sold.

Nebula Research & Development first reported a position in AMN in Q2 2024 and held it in 3 quarters. The position peaked at $469K in Q1 2025. 248 funds tracked by Wall St. Rank hold AMN as of Q2 2025.

  • Nebula Research & Development reported no remaining AMN Healthcare position as of Q2 2025 after selling out during the quarter.
  • Nebula Research & Development sold 19,187 AMN Healthcare shares in Q2 2025, an estimated $469K.
  • Nebula Research & Development first reported a position in AMN Healthcare in Q2 2024 and held it in 3 quarters.
  • Nebula Research & Development's AMN Healthcare position peaked at $469K in Q1 2025.
  • 248 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2025.

Based on Nebula Research & Development's 13F filing for Q2 2025, filed 14 Aug 2025.